← Leaderboards
Emily Von Scheven
University Of California San Francisco
$1,381,215
Attributed
$1,381,215
Total exposure
9
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,381,215 · 9
By mechanism
K23$652,031 · 1
M01$424,035 · 7
P60$305,149 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Nancy E. Lane$24,503,745
- Melvin B. Heyman$7,841,306
- Nancy L Lane$1,692
- Aditi Bhargava$3,649,255
- Thomas F Lang$6,600,253
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchSystemic Lupus ErythematosusAdolescence (12-20)Bone DensityChild (0-11)Photon AbsorptiometryChild Physical DevelopmentPatient Oriented ResearchAge DifferenceDisease /Disorder OnsetAntibody FormationAutoantibodyAutoimmune DisorderGenetic MarkersMajor Histocompatibility ComplexMhc Class Ii AntigenOsteoporosisPhospholipidsOsteopeniasBone MetabolismBone DevelopmentRacial /Ethnic DifferenceRadiography
Grant awards (26)
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$152,782
K23 · FY2005 · RR
LONG TERM OUTCOME OF CHILDREN AND ADOLESCENTS WITH APL$92,107
M01 · FY2005 · RR
BONE MINERAL DENSITY STUDY IN SLE$68,989
M01 · FY2005 · RR
ALENDRONATE FOR THE TREATMENT OF CHILDHOOD OSTEOPENIA AND OSTEOPOROSIS$62,384
M01 · FY2005 · RR
BONE MINERAL DENSITY OF CHILDREN AND ADOLESCENTS WITH SLE$15,412
M01 · FY2005 · RR
MUTATIONS IN T AND B-CELL SIGNALING PROTEINS IN CHILDREN WITH AUTOIMMUNE DISEASE$8,073
M01 · FY2005 · RR
THE ATHEROSCLEROSIS PREVENTION IN PEDIATRIC LUPUS ERYTHEMATOSUS (APPLE) STUDY$3,303
M01 · FY2005 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$142,995
K23 · FY2004 · RR
Bone mineral density study in SLE$52,760
M01 · FY2004 · RR
Long term outcome of children and adolescents with APL$44,430
M01 · FY2004 · RR
Alendronate for the treatment of childhood osteopenia and osteoporosis$39,273
M01 · FY2004 · RR
Bone mineral density of children and adolescents with SLE$11,505
M01 · FY2004 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$128,492
K23 · FY2003 · RR
BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERTHEMATOSUS IN CHILDREN$159,181
P60 · FY2002 · AR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$127,772
K23 · FY2002 · RR
MAJOR HISTOCOMPATIBILITY COMPLEX ASSOCIATIONS WITH ANTIPHOSPHOLIPID ANTIBODIES$0
M01 · FY2002 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$99,990
K23 · FY2001 · RR
BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERTHEMATOSUS IN CHILDREN$0
P60 · FY2001 · AR
MAJOR HISTOCOMPATIBILITY COMPLEX ASSOCIATIONS WITH ANTIPHOSPHOLIPID ANTIBODIES$0
M01 · FY2001 · RR
BONE MINERAL DENSITY IN SYSTEMIC LUPUS ERTHEMATOSUS IN CHILDREN$145,968
P60 · FY2000 · AR
MAJOR HISTOCOMPATIBILITY COMPLEX ASSOCIATIONS WITH ANTIPHOSPHOLIPID ANTIBODIES$25,799
M01 · FY2000 · RR
MAJOR HISTOCOMPATIBILITY COMPLEX ASSOCIATIONS WITH ANTIPHOSPHOLIPID ANTIBODIES$0
M01 · FY2000 · RR
BONE MINERAL DENSITY OF CHILDREN / ADOLESCENTS WITH SLE$0
M01 · FY2000 · RR
BONE MINERAL DENSITY OF CHILDREN / ADOLESCENTS WITH SLE$0
M01 · FY2000 · RR
BONE MINERAL DENSITY OF CHILDREN / ADOLESCENTS WITH SLE$0
M01 · FY2000 · RR
MAJOR HISTOCOMPATIBILITY COMPLEX ASSOCIATIONS WITH ANTIPHOSPHOLIPID ANTIBODIES$0
M01 · FY2000 · RR